199 related articles for article (PubMed ID: 29630139)
21. Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment.
Pasinetti GM; Wang J; Ho L; Zhao W; Dubner L
Biochim Biophys Acta; 2015 Jun; 1852(6):1202-8. PubMed ID: 25315300
[TBL] [Abstract][Full Text] [Related]
22. Curcumin in Health and Diseases: Alzheimer's Disease and Curcumin Analogues, Derivatives, and Hybrids.
Chainoglou E; Hadjipavlou-Litina D
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183162
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective properties of curcumin in Alzheimer's disease--merits and limitations.
Chin D; Huebbe P; Pallauf K; Rimbach G
Curr Med Chem; 2013; 20(32):3955-85. PubMed ID: 23931272
[TBL] [Abstract][Full Text] [Related]
24. Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer's disease.
Porquet D; Griñán-Ferré C; Ferrer I; Camins A; Sanfeliu C; Del Valle J; Pallàs M
J Alzheimers Dis; 2014; 42(4):1209-20. PubMed ID: 25024312
[TBL] [Abstract][Full Text] [Related]
25. A potential role of the curry spice curcumin in Alzheimer's disease.
Ringman JM; Frautschy SA; Cole GM; Masterman DL; Cummings JL
Curr Alzheimer Res; 2005 Apr; 2(2):131-6. PubMed ID: 15974909
[TBL] [Abstract][Full Text] [Related]
26. Curcumin and neurodegenerative diseases: a perspective.
Darvesh AS; Carroll RT; Bishayee A; Novotny NA; Geldenhuys WJ; Van der Schyf CJ
Expert Opin Investig Drugs; 2012 Aug; 21(8):1123-40. PubMed ID: 22668065
[TBL] [Abstract][Full Text] [Related]
27. Selecting for neurogenic potential as an alternative for Alzheimer's disease drug discovery.
Prior M; Goldberg J; Chiruta C; Farrokhi C; Kopynets M; Roberts AJ; Schubert D
Alzheimers Dement; 2016 Jun; 12(6):678-86. PubMed ID: 27149904
[TBL] [Abstract][Full Text] [Related]
28. Nanoplasmonic fiber tip probe detects significant reduction of intracellular Alzheimer's disease-related oligomers by curcumin.
Liang F; Wan Y; Schaak D; Ward J; Shen X; Tanzi RE; Zhang C; Quan Q
Sci Rep; 2017 Jul; 7(1):5722. PubMed ID: 28720893
[TBL] [Abstract][Full Text] [Related]
29. Use of Curcumin, a Natural Polyphenol for Targeting Molecular Pathways in Treating Age-Related Neurodegenerative Diseases.
Maiti P; Dunbar GL
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857538
[TBL] [Abstract][Full Text] [Related]
30. The Mechanisms of Action of Curcumin in Alzheimer's Disease.
Tang M; Taghibiglou C
J Alzheimers Dis; 2017; 58(4):1003-1016. PubMed ID: 28527218
[TBL] [Abstract][Full Text] [Related]
31. Resveratrol for Alzheimer's disease.
Sawda C; Moussa C; Turner RS
Ann N Y Acad Sci; 2017 Sep; 1403(1):142-149. PubMed ID: 28815614
[TBL] [Abstract][Full Text] [Related]
32. Bivalent ligands incorporating curcumin and diosgenin as multifunctional compounds against Alzheimer's disease.
Chojnacki JE; Liu K; Saathoff JM; Zhang S
Bioorg Med Chem; 2015 Nov; 23(22):7324-31. PubMed ID: 26526742
[TBL] [Abstract][Full Text] [Related]
33. Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway.
Hoppe JB; Coradini K; Frozza RL; Oliveira CM; Meneghetti AB; Bernardi A; Pires ES; Beck RC; Salbego CG
Neurobiol Learn Mem; 2013 Nov; 106():134-44. PubMed ID: 23954730
[TBL] [Abstract][Full Text] [Related]
34. The impact of curcumin and its modified formulations on Alzheimer's disease.
Farkhondeh T; Samarghandian S; Pourbagher-Shahri AM; Sedaghat M
J Cell Physiol; 2019 Aug; 234(10):16953-16965. PubMed ID: 30847942
[TBL] [Abstract][Full Text] [Related]
35. Curcumin Decreases Hyperphosphorylation of Tau by Down-Regulating Caveolin-1/GSK-3β in N2a/APP695swe Cells and APP/PS1 Double Transgenic Alzheimer's Disease Mice.
Sun J; Zhang X; Wang C; Teng Z; Li Y
Am J Chin Med; 2017; 45(8):1667-1682. PubMed ID: 29132216
[TBL] [Abstract][Full Text] [Related]
36. A Combination of Resveratrol and Curcumin is Effective Against Aluminum Chloride-Induced Neuroinflammation in Rats.
Zaky A; Bassiouny A; Farghaly M; El-Sabaa BM
J Alzheimers Dis; 2017; 60(s1):S221-S235. PubMed ID: 28222524
[TBL] [Abstract][Full Text] [Related]
37. Protective effect of rhubarb derivatives on amyloid beta (1-42) peptide-induced apoptosis in IMR-32 cells: a case of nutrigenomic.
Misiti F; Sampaolese B; Mezzogori D; Orsini F; Pezzotti M; Giardina B; Clementi ME
Brain Res Bull; 2006 Dec; 71(1-3):29-36. PubMed ID: 17113925
[TBL] [Abstract][Full Text] [Related]
38. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model.
Garcia-Alloza M; Borrelli LA; Rozkalne A; Hyman BT; Bacskai BJ
J Neurochem; 2007 Aug; 102(4):1095-104. PubMed ID: 17472706
[TBL] [Abstract][Full Text] [Related]
39. Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents.
Viegas FPD; Gontijo VS; de Freitas Silva M; Ortiz CJC; Dos Reis Rosa Franco G; Ernesto JT; Damasio CM; Silva IMF; Campos TG; Viegas C
Curr Neuropharmacol; 2022; 20(7):1297-1328. PubMed ID: 34825873
[TBL] [Abstract][Full Text] [Related]
40. Resveratrol and Alzheimer's Disease: Mechanistic Insights.
Ahmed T; Javed S; Javed S; Tariq A; Šamec D; Tejada S; Nabavi SF; Braidy N; Nabavi SM
Mol Neurobiol; 2017 May; 54(4):2622-2635. PubMed ID: 26993301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
